West Pharmaceutical Services, Inc. Stock
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
04:02:20 10/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 366.00 USD | +0.75% |
|
+0.28% | +33.02% |
| Market Cap | 25.76B 23B 21.4B 19.46B 36.75B 2,493B 36.91B 258B 101B 1,271B 96.72B 94.61B 4,078B | P/E 2026 * |
42.7x | P/E 2027 * | 37.1x |
|---|---|---|---|---|---|
| Enterprise Value | 25.19B 22.5B 20.93B 19.03B 35.94B 2,438B 36.1B 252B 98.69B 1,243B 94.59B 92.52B 3,988B | EV / Sales 2026 * |
7.46x | EV / Sales 2027 * | 6.91x |
| Free-Float |
92.88% | Yield 2026 * |
0.23% | Yield 2027 * | 0.27% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| WST | Delayed | |
CBOE
| WST | Real-time | |
|
London S.E.
| 0ADY | Delayed | |
|
Boerse Muenchen
| WPS | Real-time | |
|
Deutsche Boerse AG
| WPS | Delayed | |
|
Tradegate
| WPS | Real-time | |
|
Börse Stuttgart
| WPS | Delayed | |
|
Berne S.E.
| WPS | End-of-day quote | |
|
Borsa Italiana
| 1WST | End-of-day quote |
Last Transcript: West Pharmaceutical Services, Inc.
| 1 day | +0.75% | ||
| 1 week | +0.28% | ||
| Current month | -1.28% | ||
| 1 month | +6.32% | ||
| 3 months | +3.47% | ||
| 6 months | +42.66% | ||
| Current year | +33.02% |
| 1 week | 359.49 |  | 381.16 |
| 1 month | 345.15 | | 382.71 |
| Current year | 223.83 | | 386 |
| 1 year | 223.83 | | 386 |
| 3 years | 187.43 | | 413.7 |
| 5 years | 187.43 | | 475 |
| 10 years | 70.17 | | 475.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michel Lagarde
CEO | Chief Executive Officer | 52 | 31/08/2026 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 04/08/2025 |
Devesh Mathur
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Buthman
BRD | Director/Board Member | 65 | 01/02/2011 |
Douglas Michels
BRD | Director/Board Member | 69 | 07/03/2011 |
William Feehery
BRD | Director/Board Member | 56 | 12/02/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/9/26 | Other | Director | 44 | 0.0001% | ||
| 15/9/26 | Exercice | Head of Human Resources | 7,572 | 0.0108% | ||
| 8/9/26 | Free | Chief Executive Officer | 51,798 | 0.0736% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.75% | +0.28% | +39.82% | -5.49% | 25.76B | |
| +1.13% | +2.15% | -24.87% | +2.09% | 172B | |
| +0.83% | +2.43% | -7.30% | +16.15% | 113B | |
| +0.13% | +0.69% | -23.94% | +1.05% | 106B | |
| +2.34% | +2.49% | -46.47% | -11.84% | 75.31B | |
| +0.78% | +4.79% | +1.84% | +72.29% | 61.8B | |
| +0.12% | +3.62% | +15.06% | +65.87% | 52.93B | |
| +0.55% | +3.93% | -1.51% | -31.24% | 50.05B | |
| +0.95% | -0.08% | -15.93% | +14.93% | 40.81B | |
| +1.45% | +1.83% | - | - | 31.81B | |
| Average | +0.90% | +2.03% | -7.03% | +13.76% | 73.04B | |
| Weighted average by Cap. | +0.91% | +2.15% | -14.24% | +11.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.38B 3.01B 2.8B 2.55B 4.82B 327B 4.84B 33.75B 13.22B 167B 12.67B 12.4B 534B | 3.59B 3.2B 2.98B 2.71B 5.12B 347B 5.14B 35.87B 14.05B 177B 13.47B 13.18B 568B |
| Net income | 621M 555M 516M 470M 887M 60.15B 891M 6.21B 2.43B 30.66B 2.33B 2.28B 98.41B | 710M 634M 590M 537M 1.01B 68.73B 1.02B 7.1B 2.78B 35.04B 2.67B 2.61B 112B |
| Net Debt | -569M -508M -473M -430M -812M -55.05B -815M -5.69B -2.23B -28.07B -2.14B -2.09B -90.07B | -973M -869M -809M -736M -1.39B -94.22B -1.4B -9.73B -3.81B -48.03B -3.66B -3.58B -154B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/10/26 | US$366.00 | +0.75% | 480,215 |
| 08/10/26 | US$363.27 | -0.88% | 461,704 |
| 07/10/26 | US$366.48 | -1.65% | 438,035 |
| 06/10/26 | US$372.64 | -1.09% | 401,401 |
| 05/10/26 | US$376.76 | +3.23% | 682,772 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WST Stock
Select your edition
All financial news and data tailored to specific country editions
